A phase II/III study of cediranib and olaparib combination compared to cediranib or olaparib alone or standard of care chemotherapy, in platinum-resistant ovarian cancer (NRG-GY005)
Jung‐Min Lee,Brady Mark,Austin Miller,Richard G. Moore,Helen Mackay,Leah McNally,Jayanthi Lea,Stéphanie Lheureux,David A. Bender,Linda Duska,Guilherme Cantuaria,Juraj Kavecansky,Charles A. Leath,Matthew A. Powell,Mark G. Cadungog,Peter G. Rose,Michael A. Bookman,Elise C. Kohn,Angeles Alvarez Secord
PDF的下载单位、IP信息已删除
(2025-6-4)
浮游
Criminology34
ceeray23
无极微光
asdfzxcv
进击的PhD
smottom
王丽娟
香蕉诗蕊
wy.he
BowieHuang
个性的荆
归尘
小青椒
专注的问寒
Jared
yznfly
Mic
三岁
佳佳
Twonej
lilili
BareBear
yyds
皖公网安备34019202002308
